Search

for
Search:

Research

5 / 1000+ results

research Ovarian vein sampling, and serum and urine testosterone monitoring in ovarian Leydig cell tumors: A report of two cases

2 citations , November 2019 in “Case reports in women's health”

In this study, two women with hyperandrogenic symptoms were found to have ovarian Leydig cell tumors after selective ovarian venous sampling and salpingo-oophorectomy, leading to a decline in testosterone levels post-surgery.

The Prevalence of Androgenetic Alopecia with Hormone Therapy in Transgender Men: A Systematic Review and Single-Arm Meta-Analysis

research 53039 The prevalence of androgenetic alopecia with hormone therapy in transgender men: a systematic review and single-arm meta-analysis

September 2024 in “Journal of the American Academy of Dermatology”

This study aims to evaluate the prevalence of androgenetic alopecia in transgender men undergoing testosterone therapy, noting that such hormone treatment can lead to dermatological issues that significantly affect their quality of life. Results are not reported in the abstract.

research Side effects of androgen deprivation therapy: monitoring and minimizing toxicity

228 citations , February 2003 in “Urology”

This article discusses the side effects of androgen deprivation therapy for nonmetastatic prostate cancer, highlighting the need for clinical trials to systematically study these effects.

research Hair Follicles as a Critical Model for Monitoring the Circadian Clock

5 citations , January 2023 in “International Journal of Molecular Sciences”

This review discusses the expression of circadian genes in hair follicles and their potential for monitoring circadian-rhythm-related conditions, reporting no clinical results; the authors suggest combining hair sampling with other assessments for better insight.

research Cost-effectiveness analysis of laboratory monitoring in newly diagnosed telogen effluvium patients

June 2024 in “Archives of dermatological research”

Targeted testing for telogen effluvium patients can save healthcare costs.

View more "hormone monitoring" in research →

Community Join

5 / 1000+ results

community Planning to take a break from Fin for a 2 months then start with Pyrilutamide - What hormone levels to test?

2 upvotes 3 years ago

The user plans to pause finasteride for two months to test its effects on mood and productivity, then switch to Pyrilutamide while monitoring hormone levels. Concerns are raised about potential hair loss and the effectiveness of Pyrilutamide compared to finasteride.

community 0.005% topical fin any experience?

4 upvotes 2 weeks ago

The conversation discusses using low concentrations of topical finasteride (0.005% and 0.02%) for hair loss due to concerns about side effects. One user suggests starting with higher doses and monitoring hormone levels, sharing their positive experience with higher doses of finasteride and dutasteride without side effects.

community Is Cialis the best option for when you have ED on DHT blockers?

in Chat 61 upvotes 2 months ago

The conversation discusses using finasteride for hair loss and its side effect of erectile dysfunction (ED), with some users suggesting reducing the dose to 0.5mg to minimize side effects. Cialis is recommended for managing ED, and other suggestions include monitoring hormone levels and considering supplements like DIM or L-Citrulline.

community Minoxidil is working for me – just 3 months in! (No fin, no microneedling

in Is this regrowth? 48 upvotes 1 year ago

A 36-year-old experienced slow, diffuse hair thinning over 15 years and saw significant improvement using 5% topical minoxidil alone for 3 months, without finasteride or microneedling. The user is pleased with the results, noting increased hair density and no visible scalp, and plans to continue monitoring progress without using hormone-affecting treatments.

community What happens if you combine dutasteride and a aromataze inhibitor?

4 upvotes 7 years ago

Combining dutasteride and an aromatase inhibitor may increase testosterone levels significantly, potentially enhancing athletic performance but also posing health risks like elevated blood pressure and worsened cholesterol. The user is experimenting with dutasteride, anastrozole, minoxidil, and ketoconazole shampoo to manage hair loss and estradiol levels, while monitoring side effects and hormone levels.

View more "hormone monitoring" in community →

Learn

6 / 801 results

learn Cyproterone

a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

learn Neem Oil

natural substance from Neem tree with medicinal and pesticidal properties

learn Centella

Sensitive to hormones? A centella scalp mask may help ease hidden inflamm Centella asiatica has anti-inflammatory and wound-healing effects in animal and cell studies, but no published research has tested a centella scalp mask on the human scalp, in hormonal contexts or otherwise, and no community reports were found of one being used this way.

learn Estradiol

Why is Estradiol used to treat hair loss in women and transgender people undergoing hormone therapy? Estradiol helps treat hair loss by balancing hormones and supporting hair follicle health.
Is applying Estradiol directly to the scalp effective for hormone-related hair thinning? Applying Estradiol directly to the scalp may help with hormone-related hair thinning.

learn procapil

Want to stop hormonal hair loss without touching your hormone levels? Procapil could block the enzyme doing the damage. Procapil's supplier describes it as inhibiting 5-alpha reductase at the scalp without changing hormone levels, but the published support is cell and animal work plus one small human study of a caffeine-plus-Procapil formula. It is a cosmetic ingredient, not an approved hair-loss treatment, and no trial has compared it with finasteride or minoxidil.

learn Clascoterone

Can I use clascoterone if I'm undergoing gender-affirming hormone therapy? No published clinical trial has tested clascoterone in people on gender-affirming hormone therapy, so its safety in that group is unknown. The FDA label reports low systemic exposure and no described effect on blood testosterone, but it also records HPA-axis suppression and raised potassium in a small minority of subjects.

View more "hormone monitoring" in learn →

Clinics

6 / 71 results

All 71 clinic results →

Experts

— no results

Try a deeper search in experts →